Arginine metabolic pathways involved in the modulation of tumor-induced angiogenesis by macrophages
- PMID: 12459493
- DOI: 10.1016/s0014-5793(02)03682-7
Arginine metabolic pathways involved in the modulation of tumor-induced angiogenesis by macrophages
Abstract
Neovascularization, an essential step for tumor progression and metastasis development, can be modulated by the presence of macrophages (Mps) in the tumor microenvironment. The ability of Mps to regulate the angiogenicity of the LMM3 tumor cell line was studied. Peritoneal Mps from LMM3 tumor-bearing mice (TMps) potentiate in vivo LMM3 angiogenicity. These results were confirmed by CD31 immunoblotting assays. The activity of TMps depended on nitric oxide synthase (NOS) and arginase (A) activity. By immunoblotting we evidenced that AI and AII isoforms were up-regulated in TMps while the inducible and neuronal NOS isoforms were highly expressed in normal Mps. TMps might positively modulate tumor growth by stimulating angiogenic cascade mainly through polyamine synthesis.
Similar articles
-
Muscarinic receptors participation in angiogenic response induced by macrophages from mammary adenocarcinoma-bearing mice.Breast Cancer Res. 2005;7(3):R345-52. doi: 10.1186/bcr1005. Epub 2005 Mar 4. Breast Cancer Res. 2005. PMID: 15987429 Free PMC article.
-
Proliferative actions of muscarinic receptors expressed in macrophages derived from normal and tumor bearing mice.Biochim Biophys Acta. 2008 Feb;1782(2):82-9. doi: 10.1016/j.bbadis.2007.11.005. Epub 2007 Nov 22. Biochim Biophys Acta. 2008. PMID: 18078830
-
Macrophages derived from septic mice modulate nitric oxide synthase and angiogenic mediators in the heart.J Cell Physiol. 2013 Jul;228(7):1584-93. doi: 10.1002/jcp.24320. J Cell Physiol. 2013. PMID: 23335284
-
Regulation of nitric oxide production by arginine metabolic enzymes.Biochem Biophys Res Commun. 2000 Sep 7;275(3):715-9. doi: 10.1006/bbrc.2000.3169. Biochem Biophys Res Commun. 2000. PMID: 10973788 Review.
-
Arginase in glomerulonephritis.Kidney Int. 2002 Mar;61(3):876-81. doi: 10.1046/j.1523-1755.2002.00236.x. Kidney Int. 2002. PMID: 11849441 Review.
Cited by
-
The Role of Tumor Metabolic Reprogramming in Tumor Immunity.Int J Mol Sci. 2023 Dec 13;24(24):17422. doi: 10.3390/ijms242417422. Int J Mol Sci. 2023. PMID: 38139250 Free PMC article. Review.
-
Prim-O-glucosylcimifugin enhances the antitumour effect of PD-1 inhibition by targeting myeloid-derived suppressor cells.J Immunother Cancer. 2019 Aug 28;7(1):231. doi: 10.1186/s40425-019-0676-z. J Immunother Cancer. 2019. PMID: 31462297 Free PMC article.
-
Metabolic reprogramming in hepatocellular carcinoma: a bibliometric and visualized study from 2011 to 2023.Front Pharmacol. 2024 Jul 16;15:1392241. doi: 10.3389/fphar.2024.1392241. eCollection 2024. Front Pharmacol. 2024. PMID: 39086383 Free PMC article.
-
Prim-O-glucosylcimifugin alleviates influenza virus-induced pneumonia in mice by inhibiting the TGF-β1/PI3KCD/MSK2/RELA signalling pathway.Arch Virol. 2024 Oct 29;169(11):232. doi: 10.1007/s00705-024-06158-5. Arch Virol. 2024. PMID: 39467851
-
Diclofenac inhibits tumor growth in a murine model of pancreatic cancer by modulation of VEGF levels and arginase activity.PLoS One. 2010 Sep 15;5(9):e12715. doi: 10.1371/journal.pone.0012715. PLoS One. 2010. PMID: 20856806 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources